Cargando…
Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2
The COVID pandemic fueled by emerging SARS-CoV-2 new variants of concern remains a major global health concern, and the constantly emerging mutations present challenges to current therapeutics. The spike glycoprotein is not only essential for the initial viral entry, but is also responsible for the...
Autores principales: | Yu, Shi, Zheng, Xu, Zhou, Yanqiu, Gao, Yuhui, Zhou, Bingjie, Zhao, Yapei, Li, Tingting, Li, Yunyi, Mou, Jiabin, Cui, Xiaoxian, Yang, Yuying, Li, Dianfan, Chen, Min, Lavillette, Dimitri, Meng, Guangxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664894/ https://www.ncbi.nlm.nih.gov/pubmed/37948454 http://dx.doi.org/10.1371/journal.ppat.1011789 |
Ejemplares similares
-
A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
por: Yao, Hebang, et al.
Publicado: (2021) -
SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
por: Yu, Shi, et al.
Publicado: (2021) -
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy
por: Meng, Lu, et al.
Publicado: (2023) -
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2
por: Li, Tingting, et al.
Publicado: (2022) -
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)